Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinoma, Esophageal”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00909402
What this trial is testing

BMS-833923 With Cisplatin and Capecitabine in Inoperable, Metastatic Gastric, Gastroesophageal, or Esophageal Adenocarcinomas

Who this might be right for
Stomach NeoplasmsEsophageal Neoplasms
Bristol-Myers Squibb 39
Not applicableStudy completedNCT02100189
What this trial is testing

Esophageal Cytology With FISH in Detecting Esophageal Cancer

Who this might be right for
DysphagiaDysplasiaEsophageal Adenocarcinoma+5 more
OHSU Knight Cancer Institute 50
Testing effectiveness (Phase 2)Study completedNCT01932580
What this trial is testing

Pilot Study of Perioperative Docetaxel, Oxaliplatin, and 5-Fluorouracil (FLOT) in Gastroesophageal Adenocarcinoma

Who this might be right for
Gastric AdenocarcinomaEsophageal Adenocarcinoma
McGill University 10
Testing effectiveness (Phase 2)Looking for participantsNCT06819566
What this trial is testing

Prophylactic Endoscopic Variceal Ligation in Patients With High-risk Esophageal Varices Receiving Atezo/Bev for HCC

Who this might be right for
Hepatocellular CarcinomaEsophageal VarixBleeding Esophageal Varices
Asan Medical Center 44
Early research (Phase 1)Study completedNCT04121286
What this trial is testing

JAB-3312 in Adult Patients With Advanced Solid Tumors in China

Who this might be right for
Non-small Cell Lung CancerColorectal CancerPancreatic Ductal Carcinoma+4 more
Allist Pharmaceuticals, Inc. 17
Testing effectiveness (Phase 2)Study completedNCT03365791
What this trial is testing

PDR001 Plus LAG525 for Patients With Advanced Solid and Hematologic Malignancies

Who this might be right for
Small Cell Lung CancerGastric AdenocarcinomaEsophageal Adenocarcinoma+5 more
Novartis Pharmaceuticals 76
Not applicableEnded earlyNCT05489250
What this trial is testing

The PLATON Network

Who this might be right for
Hepatocellular CancerCholangiocarcinomaGallbladder Cancer+3 more
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 565
Not applicableLooking for participantsNCT07375420
What this trial is testing

Will a Pre-therapy Exercise Intervention Improve the Outcomes of Patients With Advanced Oesophageal Cancer?

Who this might be right for
Oesophageal AdenocarcinomaT CellsTumor Microenvironment+1 more
University of Surrey 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT02998268
What this trial is testing

Study of Pembrolizumab in Locally Advanced Esophageal Adenocarcinoma

Who this might be right for
Esophageal Adenocarcinoma
Weill Medical College of Cornell University 42
Early research (Phase 1)Active Not RecruitingNCT05215574
What this trial is testing

Study of NGM831 as Monotherapy and in Combination With Pembrolizumab or Pembrolizumab and NGM438 in Advanced or Metastatic Solid Tumors

Who this might be right for
Pancreatic CancerBreast CancerGastric Cancer+13 more
NGM Biopharmaceuticals, Inc 130
Testing effectiveness (Phase 2)Ended earlyNCT01980810
What this trial is testing

First Line Chemotherapy for Advanced Cancer

Who this might be right for
Gastric Cancer
Chinese Academy of Medical Sciences 36
Large-scale testing (Phase 3)UnknownNCT02509286
What this trial is testing

Perioperative Chemotherapy Compared To Neoadjuvant Chemoradiation in Patients With Adenocarcinoma of the Esophagus

Who this might be right for
Esophageal Adenocarcinoma (UICC TNM7)Adenocarcinoma of the Esophagogastric Junction
University Hospital Schleswig-Holstein 438
Testing effectiveness (Phase 2)UnknownNCT05942573
What this trial is testing

Continuation of Serplulimab Plus Chemotherapy After First Progression in Advanced Gastric or Gastro-oesophageal Junction Adenocarcinoma: an Open-label, Randomised Phase II Trial

Who this might be right for
Gastric Cancer (GC) Gastroesophageal Junction Cancer (GEJ)
Tianjin Medical University Cancer Institute and Hospital 107
Not applicableLooking for participantsNCT07309991
What this trial is testing

Postoperative Hypoxemia Increases the Risk of Anastomotic Leak After Radical Esophagectomy

Who this might be right for
Esophageal CarcinomaEsophageal AdenocarcinomaEsophagectomy+2 more
Sun Yat-sen University 2,500
Testing effectiveness (Phase 2)Study completedNCT00718913
What this trial is testing

Postoperative Chemotherapy and Chemo-radiotherapy for Resected Gastric Cancer

Who this might be right for
Gastric Cancer
Hellenic Oncology Research Group 40
Early research (Phase 1)Study completedNCT00019513
What this trial is testing

Combination Chemotherapy in Treating Patients With Recurrent, Refractory, or Metastatic Solid Tumors or Lymphomas

Who this might be right for
Colorectal CancerEsophageal CancerExtrahepatic Bile Duct Cancer+7 more
National Institutes of Health Clinical Center (CC) 108
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07680569
What this trial is testing

Phase Ib/IIa Open-label Study, to Evaluate Safety, Tolerability, and Antitumor Activity of HCB101 in Combination With Multiple Agents in Subjects With Advanced Gastric or Gastro-esophageal (GEJ) Adenocarcinoma

Who this might be right for
GC/GEJC
Kaohsiung Medical University Chung-Ho Memorial Hospital 40
Large-scale testing (Phase 3)Study completedNCT04499924
What this trial is testing

Tucatinib, Trastuzumab, Ramucirumab, and Paclitaxel Versus Paclitaxel and Ramucirumab in Previously Treated HER2+ Gastroesophageal Cancer

Who this might be right for
Gastric AdenocarcinomaGastroesophageal Junction AdenocarcinomaEsophageal Adenocarcinoma
Seagen Inc. 17
Testing effectiveness (Phase 2)Ended earlyNCT02234180
What this trial is testing

Regorafenib in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction Who Have Completed Chemoradiation Therapy and Surgery

Who this might be right for
Adenocarcinoma of the Gastroesophageal JunctionStage IIB Esophageal AdenocarcinomaStage IIIA Esophageal Adenocarcinoma+2 more
Academic and Community Cancer Research United 3
Testing effectiveness (Phase 2)Study completedNCT00009880
What this trial is testing

Combination Chemotherapy Plus Radiation Therapy With or Without Fluorouracil in Treating Patients With Cancer of the Esophagus or Stomach

Who this might be right for
Esophageal CancerGastric Cancer
Radiation Therapy Oncology Group
Next Page